Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Jan 15, 2025 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
Top 10 MS news stories of 2024
Dec 31, 2024 · The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk factors. Top 10 MS news stories of 2024
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
News; Top 10 MS stories of 2023 Top 10 MS stories of 2023. Of most interest to readers was news on potential treatments, triggers. by Marisa Wexler, MS | January 2, 2024.
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · January 15, 2025 News by Marisa Wexler, MS. Phase 1/2 trial will test cell therapy rese-cel in relapsing, progressive MS. December 18, 2024 News by Steve Bryson, PhD.
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
Jan 5, 2024 · December 6, 2024 News by Esteban Domínguez Cerezo, MS. Phase 2 trial testing foralumab in nonactive SPMS adds 6 US sites. November 7, 2024 News by Marisa Wexler, MS.
The MS News Today Podcast - Multiple Sclerosis News Today
After 24 years with the National MS Society, most recently as Chief Advocacy, Services and Science Officer, Dr. Tim Coetzee is the new President and CEO of the Society.
MS news notes: Vaccines, migraines, eye-tracking technology
Sep 18, 2023 · The MS News Today story “No greater risk of hospitalization found after vaccines in MS in study” reports on a nationwide study in France involving over 100,000 people, that “found no ...
MS news notes: Stem cell therapy, genetic variant, diet
Jul 3, 2023 · The MS News Today article “Stem cell therapy highly effective in active RRMS: Real-world study” reports that nearly 80% of participants with highly active relapsing-remitting multiple ...
MS news notes: Vumerity, herpes virus, caregivers
Nov 27, 2023 · Final results are in from the EVOLVE-MS-1 clinical trial for patients with relapsing-remitting MS (RRMS) who were treated with Vumerity (diroximel fumarate), and the news is quite positive, as MS ...
Paramagnetic rim lesions linked to MS disability progression
Dec 16, 2024 · January 2, 2025 News by Marisa Wexler, MS. MS treatments don’t raise miscarriage, birth defect risk: Study. December 18, 2024 News by Steve Bryson, PhD.